+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07159711

Assessing Seismocardiography for Fitness Estimation and Outcome Prediction in Oesophageal Cancer Surgery

Led by Guy's and St Thomas' NHS Foundation Trust · Updated on 2026-09-14

164

Participants Needed

4

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Oesophageal cancer is a leading cause of cancer deaths worldwide, with surgery and chemotherapy as common curative treatments. However, these treatments carry significant risks, making patient selection and improving physical fitness crucial to minimize complications. This research evaluates a new device called Seismofit, which estimates physical fitness quickly and non-invasively using heart vibrations, compared to the traditional and more time-consuming Cardiopulmonary Exercise Testing CPET. The study aims to see if Seismofit can predict complications and hospital stay in patients undergoing oesophageal cancer treatment. Participants will undergo Seismofit assessments at various points during their treatment, which includes chemotherapy or chemoradiotherapy followed by surgery. Seismofit uses a small device placed on the chest to measure heart vibrations and, combined with personal data like height and age, estimates fitness within minutes. This study will compare Seismofits accuracy to CPET results and evaluate its ability to stratify patients by fitness level and predict treatment outcomes. Throughout the study, participants will have Seismofit measurements alongside standard care. Researchers will collect data on complications such as pneumonia, overall complication rates, hospital length of stay, intensive care unit stay, and anastomotic leak rates over two years. The study will also assess chemotherapy compliance and tolerability. By monitoring these outcomes, the research aims to validate Seismofit as a practical tool for fitness assessment in oesophageal cancer patients.

CONDITIONS

Brief Title

Evaluation of Seismocardiography(SCG) for Assessing Fitness and Predicting Outcomes in Oesophageal Cancer Surgery

Research Team

K

Kesav Aditya Vijayagopal, DMS

A

Andrew Davies, MD FRCS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here